Cargando…

Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report

BACKGROUND: Since post-infarction heart failure (HF) determines a great morbidity and mortality, and given the physiopathology implications of advanced glycation end products (AGE) in the genesis of myocardial dysfunction, it was intended to analyze the prognostic value of these molecules in order t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raposeiras-Roubín, Sergio, Rodiño-Janeiro, Bruno K, Paradela-Dobarro, Beatriz, Grigorian-Shamagian, Lilian, García-Acuña, José M, Aguiar-Souto, Pablo, Jacquet-Hervet, Michel, Reino-Maceiras, María V, Álvarez, Ezequiel, González-Juanatey, José R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489693/ https://www.ncbi.nlm.nih.gov/pubmed/22909322 http://dx.doi.org/10.1186/1475-2840-11-102

Ejemplares similares

Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome
por: Raposeiras-Roubín, Sergio, et al.
Publicado: (2013)

Current status of NADPH oxidase research in cardiovascular pharmacology
por: Rodiño-Janeiro, Bruno K, et al.
Publicado: (2013)

Evolution and bad prognostic value of advanced glycation end products after acute heart failure: relation with body composition
por: Paradela-Dobarro, Beatriz, et al.
Publicado: (2017)

Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches
por: Vélez, Paula, et al.
Publicado: (2016)

Chronic total occlusions in Artsakh: The last frontier
por: Gutiérrez-Chico, Juan Luis, et al.
Publicado: (2022)

Postoperative left ventricular thrombosis and transthoracic echocardiography: is it enough?
por: Pardal, Cristina Barreiro, et al.
Publicado: (2011)

Correction: The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease – expert panel meeting report
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2023)

The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease – expert panel meeting report
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2023)

Harnessing the heart’s resistance to malignant tumors: cardiac-derived extracellular vesicles decrease fibrosarcoma growth and leukemia-related mortality in rodents
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2017)

Is 6-month GRACE risk score a useful tool to predict stroke after an acute coronary syndrome?
por: Álvarez-Álvarez, Belén, et al.
Publicado: (2014)

Introducción: novedades del año 2020
por: Raposeiras-Roubin, Sergio, et al.
Publicado: (2021)

Introducción: novedades del año 2021
por: Raposeiras-Roubín, Sergio, et al.
Publicado: (2022)

Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection
por: Melendo-Viu, María, et al.
Publicado: (2023)

Role of Corticotropin-releasing Factor in Gastrointestinal Permeability
por: Rodiño-Janeiro, Bruno K, et al.
Publicado: (2015)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2021)

Bleeding risk assessment in elderly patients with acute coronary syndrome
por: Riobóo-Lestón, Lucía, et al.
Publicado: (2019)

Gestión clínica en el área cardiovascular. Medir para mejorar
por: González-Juanatey, José R., et al.
Publicado: (2021)

Clinical management in cardiology. Measurement as a means to improvement
por: González-Juanatey, José R., et al.
Publicado: (2021)

Comparison between CHA(2)DS(2)-VASc and the new R(2)CHADS(2) and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation
por: Abumuaileq, Rami Riziq-Yousef, et al.
Publicado: (2015)

The Essential Need for a Validated Potency Assay for Cell-Based Therapies in Cardiac Regenerative and Reparative Medicine. A Practical Approach to Test Development
por: Gómez-Cid, Lidia, et al.
Publicado: (2021)

Effects of Weight Loss on Advanced Glycation End Products in Subjects with and without Diabetes: A Preliminary Report
por: Deo, Permal, et al.
Publicado: (2017)

Eosinophils in the Gastrointestinal Tract: Key Contributors to Neuro-Immune Crosstalk and Potential Implications in Disorders of Brain-Gut Interaction
por: Salvo-Romero, Eloísa, et al.
Publicado: (2022)

A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies
por: Rodiño-Janeiro, Bruno K., et al.
Publicado: (2018)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation
por: Doki, Yuri, et al.
Publicado: (2023)

MMP-2 and sTNF-R1 Variability in Patients with Essential Hypertension: 1-Year Follow-Up Study
por: Carpena, Núria, et al.
Publicado: (2012)

Alcoholic Liver Disease Is Associated with Elevated Plasma Levels of Novel Advanced Glycation End-Products: A Preliminary Study
por: Litwinowicz, Kamil, et al.
Publicado: (2022)

The downregulation of ΔNp63 in p53-deficient mouse epidermal tumors favors metastatic behavior
por: Bornachea, Olga, et al.
Publicado: (2015)

COVID-19 y tratamiento guiado con tests de diagnóstico bioquímicos y moleculares para reducir el daño cardiaco y la cardiotoxicidad
por: Eiras, Sonia, et al.
Publicado: (2020)

COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity
por: Eiras, Sonia, et al.
Publicado: (2020)

Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value
por: Almengló, Cristina, et al.
Publicado: (2021)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

Advanced Glycation End Products in Health and Disease
por: Reddy, V. Prakash, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

Enhanced oxidative stress and damage in glycated erythrocytes
por: Turpin, Chloé, et al.
Publicado: (2020)

Rejuvenating effects of young extracellular vesicles in aged rats and in cellular models of human senescence
por: Grigorian Shamagian, Lilian, et al.
Publicado: (2023)

Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments
por: Martins, La Salete, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nnvl63mvcajuck9trh4tjek1fq